Victoza (Liraglutide) Tablet

Description

Description

This page contains brief details about the drug liraglutide, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

Liraglutide is an anti-diabetic medication which was approved for its medical use on 25th January 2010.

Mechanism of Action of Liraglutide

Liraglutide is a glucagon-like peptide-1 agonist which is coupled to adenylate cyclase. GLP-1 stimulates the release of insulin and lowers glucose levels. It works by inhibiting glucagon secretion, delaying gastric emptying, and reducing the death of islet cells. It decreases hormones that raise blood sugar levels, slow digestion and reduce appetite.

Uses of Liraglutide

Liraglutide is a glucagon-like peptide-1 agonist which is coupled to adenylate cyclase. GLP-1 stimulates the release of insulin and lowers glucose levels. It works by inhibiting glucagon secretion, delaying gastric emptying, and reducing the death of islet cells. It decreases hormones that raise blood sugar levels, slow digestion and reduce appetite.

Liraglutide Dosage available

Liraglutide is available as a solution for injection in doses of 0.6 mg, 1.2 mg, or 1.8 mg. It is intended for subcutaneous administration into the abdomen or thigh. Only use if the solution is clear, colorless, and contains no particles. Do not double the dose to compensate for the one you missed. Even if the needle is replaced, avoid sharing Liraglutide with other patients.